Kaohsiung, Taiwan

Ing-Jun Chen

USPTO Granted Patents = 16 

Average Co-Inventor Count = 1.1

ph-index = 3

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1993-2013

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Ing-Jun Chen: Innovator in Pharmaceutical Patents

Introduction

Ing-Jun Chen is a prominent inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceuticals, holding a total of 16 patents. His work focuses on innovative solutions that address critical health issues, particularly in the area of osteoporosis and drug formulations.

Latest Patents

Among his latest patents is a theophylline derivative that inhibits osteoporosis. This invention is characterized by its pharmaceutical functions that protect against bone resorption and inflammatory mediator infiltration. Another notable patent involves processes for preparing amine salts of sildenafil analogues. This series of amine salts includes specific structures that are defined in the patent specification, showcasing their potential as pro-drug active forms with various pharmaceutical functions.

Career Highlights

Ing-Jun Chen has worked with reputable organizations, including the National Science Council. His career is marked by a commitment to advancing pharmaceutical research and development, contributing to innovative solutions that improve health outcomes.

Collaborations

Throughout his career, Ing-Jun Chen has collaborated with notable colleagues, including Tong-Ho Lin and Chun-Nan Lin. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.

Conclusion

Ing-Jun Chen's contributions to pharmaceutical innovations demonstrate his dedication to improving health through scientific advancements. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…